📰 Recursion Pharmaceuticals News
Page 21 - Recursion Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Recursion Pharmaceuticals. Real-time updates on events, politics, business and more.
October 26, 2023
An imminent collapse and recession was the sentiment echoed by billionaire Stanley Druckenmiller late last year in response to an aggressive monetary policy tightening.
October 20, 2023
Allspring Global Investments Holdings LLC boosted its holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 453.7% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 8,073 shares of the company’s stock after purchasing an additional 6,615 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Recursion Pharmaceuticals were worth $60,000 […]
October 17, 2023
Neither is doing well this year.
October 13, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $7.07, for a total transaction of $176,750.00. Following the sale, the chief financial officer now owns 900,686 shares in […]
October 13, 2023
On October 11, 2023, Michael Secora, the Chief Financial Officer (CFO) of Recursion Pharmaceuticals Inc (NASDAQ:RXRX), sold 50,000 shares of the company.
October 13, 2023
One of these players could win in AI -- and in the healthcare market, in general.
October 11, 2023
The company has grabbed plenty of headlines recently.
October 10, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares were up 7.7% during trading on Tuesday . The stock traded as high as $7.30 and last traded at $7.28. Approximately 567,886 shares traded hands during trading, a decline of 82% from the average daily volume of 3,240,086 shares. The stock had previously closed at $6.76. […]
October 8, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 8,885 shares of the business’s stock in a transaction dated Tuesday, October 3rd. The shares were sold at an average price of $7.29, for a total transaction of $64,771.65. Following the completion of the transaction, the director now owns 7,434,075 shares in the […]
October 6, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Blake Borgeson sold 8,885 shares of the business’s stock in a transaction on Tuesday, October 3rd. The stock was sold at an average price of $7.29, for a total value of $64,771.65. Following the completion of the transaction, the director now owns 7,434,075 shares of the […]